ACTRN12612000709842已完成1 期
A randomised controlled trial to evaluate the immune response to an adjuvanted 2012 seasonal trivalent inactivated influenza vaccine in adults
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Male or female
- •Age 18 years or over
- •Able to provide written informed consent
- •Willing and able to comply with the protocol for the duration of the study.
排除标准
- •History of vaccination with the 2012 seasonal influenza vaccine
- •History of serious vaccine or egg allergy
- •Women of childbearing potential, unless using a reliable and appropriate contraceptive method, specifically oral contraceptive pill, IUD or mechanical barrier device.
- •Pregnant or lactating women.
- •Receipt of another investigational agent within 14 days preceding initiation of treatment.
- •Any other serious medical, social or mental condition which, in the opinion of the investigator, would be detrimental to the subjects or the study.
研究者
相似试验
已完成
不适用
Trial to study the effect of Curvic® in vaccinated population for COVID-19Vaccinated for COVID-19Infections and InfestationsCOVID-19 (SARS-CoV-2 infection)ISRCTN26285740Shreepad Shree Vallabh SSV Phytopharmaceuticals50
已完成
3 期
A prospective randomized controlled trial of immunoglobulin plus prednisolone for Kawasaki disease patients with high risk for coronary abnormalitiesKawasaki diseaseJPRN-UMIN000009524agoya University Graduate School of Medicine, Department of Pediatrics240
已完成
3 期
Randomized controlled trial to Assess Immunoglobulin plus Steroid Efficacy for Kawasaki diseaseKawasaki diseaseJPRN-UMIN000000940Randomized controlled trial to Assess Immunoglobulin plus Steroid Efficacy for Kawasaki disease (RAISE) Study Group392
进行中（未招募）
不适用
Immunogenicity and safety study of GSK Biologicals’ Infanrix-IPV+Hib™ vaccine.Primary immunisation of healthy infants in the first year of life against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b diseases.EUCTR2011-005868-25-Outside-EU/EEAGlaxoSmithKline Biologicals985
进行中（未招募）
不适用
Study to evaluate the immunogenicity and safety of GlaxoSmithKline (GSK) Biologicals’ inactivated polio vaccine (Poliorix) in infants.Primary immunisation of healthy infants in the first year of life against poliomyelitisEUCTR2011-003167-30-Outside-EU/EEAGlaxoSmithKline Biologicals1,101